These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 23073243

  • 1. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E, Ceron CS, Guimaraes DA, Prado CM, Rossi MA, Gerlach RF, Tanus-Santos JE.
    Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
    [Abstract] [Full Text] [Related]

  • 2. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
    Ceron CS, Rizzi E, Guimaraes DA, Martins-Oliveira A, Cau SB, Ramos J, Gerlach RF, Tanus-Santos JE.
    Matrix Biol; 2012 May; 31(4):261-70. PubMed ID: 22342460
    [Abstract] [Full Text] [Related]

  • 3. Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes.
    Rizzi E, Castro MM, Ceron CS, Neto-Neves EM, Prado CM, Rossi MA, Tanus-Santos JE, Gerlach RF.
    Int J Cardiol; 2013 Apr 30; 165(1):165-73. PubMed ID: 21917342
    [Abstract] [Full Text] [Related]

  • 4. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E, Guimaraes DA, Ceron CS, Prado CM, Pinheiro LC, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2014 Aug 30; 73():308-17. PubMed ID: 24933619
    [Abstract] [Full Text] [Related]

  • 5. The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension.
    Cau SB, Guimaraes DA, Rizzi E, Ceron CS, Gerlach RF, Tanus-Santos JE.
    Basic Clin Pharmacol Toxicol; 2015 Oct 30; 117(4):234-41. PubMed ID: 25816715
    [Abstract] [Full Text] [Related]

  • 6. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
    Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE.
    Redox Biol; 2015 Dec 30; 6():386-395. PubMed ID: 26343345
    [Abstract] [Full Text] [Related]

  • 7. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2013 Dec 30; 65():47-56. PubMed ID: 23806385
    [Abstract] [Full Text] [Related]

  • 8. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):224-30. PubMed ID: 18634778
    [Abstract] [Full Text] [Related]

  • 9. Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats.
    Mendes AS, Blascke de Mello MM, Parente JM, Omoto ACM, Neto-Neves EM, Fazan R, Tanus-Santos JE, Castro MM.
    Life Sci; 2020 Mar 01; 244():117153. PubMed ID: 31830479
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
    Fang J, Xu SW, Wang P, Tang FT, Zhou SG, Gao J, Chen JW, Huang HQ, Liu PQ.
    Phytomedicine; 2010 Dec 15; 18(1):58-64. PubMed ID: 20638255
    [Abstract] [Full Text] [Related]

  • 11. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function.
    da Rocha EV, Falchetti F, Pernomian L, de Mello MMB, Parente JM, Nogueira RC, Gomes BQ, Bertozi G, Sanches-Lopes JM, Tanus-Santos JE, Castro MM.
    Naunyn Schmiedebergs Arch Pharmacol; 2023 May 15; 396(5):939-949. PubMed ID: 36527481
    [Abstract] [Full Text] [Related]

  • 12. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
    Mattos BR, Bonacio GF, Vitorino TR, Garcia VT, Amaral JH, Dellalibera-Joviliano R, Franca SC, Tanus-Santos JE, Rizzi E.
    Biochem Pharmacol; 2020 Oct 15; 180():114121. PubMed ID: 32592722
    [Abstract] [Full Text] [Related]

  • 13. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
    Castro MM, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2009 May 01; 46(9):1298-307. PubMed ID: 19248829
    [Abstract] [Full Text] [Related]

  • 14. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy.
    Dool JS, Mak AS, Friberg P, Wahlander H, Hawrylechko A, Adams MA.
    Acta Physiol Scand; 1995 Dec 01; 155(4):396-404. PubMed ID: 8719259
    [Abstract] [Full Text] [Related]

  • 15. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C.
    Basic Res Cardiol; 2008 Jul 01; 103(4):319-27. PubMed ID: 18347835
    [Abstract] [Full Text] [Related]

  • 16. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
    Pereira SC, Parente JM, Belo VA, Mendes AS, Gonzaga NA, do Vale GT, Ceron CS, Tanus-Santos JE, Tirapelli CR, Castro MM.
    Atherosclerosis; 2018 Mar 01; 270():146-153. PubMed ID: 29425960
    [Abstract] [Full Text] [Related]

  • 17. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
    Marçal DM, Rizzi E, Martins-Oliveira A, Ceron CS, Guimaraes DA, Gerlach RF, Tanus-Santos JE.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan 01; 383(1):35-44. PubMed ID: 21058008
    [Abstract] [Full Text] [Related]

  • 18. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE.
    Atherosclerosis; 2008 Jun 01; 198(2):320-31. PubMed ID: 18054360
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats.
    Briest W, Homagk L, Rassler B, Ziegelhöffer-Mihalovicová B, Meier H, Tannapfel A, Leiblein S, Saalbach A, Deten A, Zimmer HG.
    Hypertension; 2004 Oct 01; 44(4):410-8. PubMed ID: 15326086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.